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The actin cross-linking  protein a-actinin binds to the 
cytoplasmic  domain of the p1 subunit  of  integrin, sug 
gesting  that a-actinin may  form a  direct  link  between 
the  actin  cytoskeleton  and  the  transmembrane  fibronec- 
tin receptor. In this study,  we  have  used  short  synthetic 
peptides to localize  the  binding site for a-actinin within 
the  cytoplasmic  domain  of p1 integrin. Four  13-residue 
peptides were tested in both an affinity chromato- 
graphic  assay  and  a  solid-phase  binding  assay. The re- 
sults  indicated  that  two  regions of sequence  contribute 
to the binding of a-actinin:  one  near  where  the  cyto- 
plasmic tail emerges  from  the  membrane  and  a  second 
segment  located  near  the C terminus of the  cytoplasmic 
tail.  This  binding  pattern  was  investigated  in more de- 
tail  using  an  adaptation of the mimotope  assay, in  which 
each of the 32 overlapping  sequential  decapeptide seg 
ments from the p1 cytoplasmic  domain  was  assembled 
on the  head  of  a  different  plastic  pin. The peptide-pin 
constructs  were  used to detect  the  binding of 12sI-a-ac- 
tinin.As  predicted  from  our  initial  results, a-actinin was 
found to bind to two  distinct  clusters of peptide seg- 
ments.  This  represents  a  novel  use of the  mimotope  pin 
assay to map interactive sites on structural  proteins. 
The question of how cells attach to a substrate has chal- 
lenged cell biologists for many  years.  In  the  last decade, the 
important role of the  integrin family of proteins  has become 
clear (Buck and Horwitz, 1987; Ruoslahti  and  Pierschbacher, 
1987; Hynes, 1987,  1992). The integrins are heterodimeric 
transmembrane  receptors for proteins of the  extracellular  ma- 
trix. Each subunit of the integrin dimer has a cytoplasmic 
domain  that  is  indirectly connected to the actin cytoskeleton. 
Thus  the  integrins form a critical linkage  between  the  extra- 
cellular  matrix  and  the  internal  structural  elements of the cell. 
In  cultured cells, integrins  are  concentrated at the sites of 
tightest  adhesion  to  the  substrate, which are called focal adhe- 
sions. A number of cytoplasmic proteins  are  also  concentrated 
in the focal adhesion (Burridge et al., 1990; Luna and Hitt, 
1992).  Much  effort has been  directed at determining how these 
cytoplasmic proteins  might be involved in  linking  the cytoplas- 
mic domains of the  integrin  subunits  to  the  actin microfila- 
ments.  Purified focal adhesion  proteins  have been studied  us- 
ing  in vitro binding  assays,  and  the  results  have  been 
incorporated  into  working models of the molecular structure of 
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the focal adhesion. The  cumulative  results  suggest that actin  is 
linked  to  the  membrane  in more than one  way  (Simon et al., 
1991). For example, integrin binds to talin (Horwitz et al., 
1986),  which also  binds  to vinculin (Otto, 1983; Wilkins et al., 
1983; Burridge  and  Mangeat, 1984),  which binds  to  a-actinin 
(Belkin  and Koteliansky, 1987; Wachsstock et  al., 19871, which 
binds to actin. This constitutes a three-protein link between 
integrin  and  actin. More recent  reports  indicate  that  talin  can 
also  bind  actin directly (Muguruma  et al., 1990;  Goldman and 
Isenberg, 1991), so that  talin  may form a direct one-protein link 
between integrin  and  actin.  It  is  not  yet known if talin  can bind 
to integrin and to actin simultaneously. Similarly, a-actinin 
binds  to  the cytoplasmic domain of the p1 subunit of integrin 
(Otey  et al., 1990). The  small  globular  head of a-actinin  binds to 
actin  and  the  larger rod-shaped domain  binds  to  integrin,  sug- 
gesting  that  a-actinin  might  also form a one-protein link be- 
tween  actin  and  integrin. 
These molecular models of the focal adhesion are based 
largely on in vitro evidence of protein-protein  interactions. How 
many of these  interactions  also occur in vivo is  not known. To 
address this question of physiological relevance, we need to 
know  more about  the  details of these  interactions  in  order  to 
design reagents  that  may  disrupt  these  linkages  in liv g cells. 
In this study, we have used synthetic peptides to map the 
binding  site for a-actinin  within  the cytoplasmic domain of p1 
integrin. 
MATERIALS AND METHODS 
Peptide Synthesis and Purification-The soluble peptides used in 
this study were  synthesized by the Protein  Chemistry  Laboratory  sup- 
ported by the University of North Carolina at Chapel Hill and the 
National Institute of Environmental  Health Sciences.  The  crude  pep- 
tides were  assembled  from  t-butoxycarbonyl  amino  acids by the solid- 
phase  method and  purified by reverse-phase  high  performance  liquid 
chromatography. The compositions of the purified peptides and their 
absolute  concentrations  were  determined by  amino  acid analysis. 
Cell  Culture--Primary  chicken  embryo  fibroblast cultures were pre- 
pared by trypsinization of skin from 9-day-old embryos. Cells were 
grown in Dulbecco’s  modified essential medium  (Life  Technologies, Inc.) 
supplemented  with  10%  fetal  bovine  serum  (Life  Technologies,  Inc.), 50 
unitdml penicillin,  and 50 unitdm1  streptomycin. 
Affinity Chromatography-The four short PI peptides (designated 
SP1-SP4) were synthesized with an additional N-terminal cysteine 
residue for  use  in  coupling the peptides  with an appropriate well  de- 
fined orientation. The  peptides  were  coupled separately to  thiopropyl- 
Sepharose 6B (Pharmacia LKB  Biotechnology Inc.) at a concentration of 
6 mg of peptiddml of resin to  give  peptide  affinity resins 1-4. 
Cultured chicken embryo fibroblasts were extracted in 1% Triton 
X-100 in column  wash  buffer (50 mM Tris acetate, 50 mM NaC1,  10 mM 
EGTA, 2 mM MgC12, pH 7.6) containing 125 pg/ml aprotinin  and  leu- 
peptin.  The  extract  was  centrifuged at 100,000 x g for 1 h at 4 “C and 
preabsorbed on a thiopropyl-Sepharose 6B column, then divided into 
four equal amounts. These extracts were separately mixed with the 
peptide affinity  resins 1-4 for  20  min at 4 “C.  The resins were  washed 
batchwise five times  with  10  volumes of column  wash  buffer and  eluted 
three  times  with two  volumes of 300 mM NaCl in column  wash  buffer. 
Immunoblot Analysis-Eluates from the peptide affinity columns 
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were  dialyzed  into 50 m~ ammonium  bicarbonate  to remove salt,  then 
lyophilized, resuspended  in gel sample  buffer,  and  electrophoresed  on 
10% polyacrylamide  gels  according  to the  method of Laemmli  (1970), 
except that  the bisacrylamide concentration was 0.13%. Immunoblot 
analysis  was  performed  essentially  as  described y  Towbin et al. (1979). 
Proteins  were  transferred  from  the gel to  nitrocellulose,  and the  nitro- 
cellulose was blocked for 1 h  in 2% bovine serum  albumin (BSA),I 0.2% 
gelatin, 0.05% Tween in Tris-buffered saline  (TBS). The nitrocellulose 
was  then  incubated  with  primary  antibody  in  the blocking buffer for 1 
h  with  constant  rocking,  washed five times for 10 min  each  in  wash 
buffer (0.2% gelatin, 0.05% Tween in  TBS),  and  incubated  in  goat  anti- 
rabbit  antibody  conjugated  to  horseradish  peroxidase (1:lOOO in block- 
ing  buffer) for 1 h  with rocking. The  blots  were  washed five times for 10 
min  each  in  wash buffer, then twice for 10 min  in TBS, and reacted  with 
0.5 mg/ml 4-chloro-1-naphthol and 50 pl of 30% H,O,. 
Solid-phase  Binding Assay-Removable microtiter  wells  (Dynatech 
Laboratories,  Inc.,  Alexandria, VA) were coated with 50 pl of full-length 
37 "C, then blocked with  2% BSA in  PBS for 1 h a t  37 "C, and  washed 
p1 peptide at  1 mg/ml in phosphate-buffered saline (PBS) for 1 h at  
with  0.1%  BSAin  PBS. 12"I-a-Actinin was  added  to the wells along  with 
a  different volume of competing  peptide (1 mg/ml)  and  diluted to  a final 
volume of 100 pVwe11 with  0.1% BSA in PBS.  The wells were  incubated 
a t  37 "C for 1 h,  then  washed five times  with  0.1% BSA in PBS  and 
counted  in  a y counter. 
Protein Purification and  lodination-a-Actinin was purified from 
chicken  gizzard as previously  described  (Feramisco and Burridge,  1980) 
and  additionally  purified by fast  protein  liquid  chromatography on a 
Mono Q column. The  a-actinin  was  labeled  with [12611iodine using  the 
Iodogen method. Iodogen (30 pl of 5 mg/ml in CHC13) was  dried  onto  the 
inside of an Eppendorf  tube  under  nitrogen.  a-Actinin  (1.5 mg/ml in 
TBS)  and  then  Na1251 (0.50 mCi;  Du  Pont-New  England  Nuclear)  were 
added  to  the  tube  and  incubated a t  4 "C for 3 min.  The  reaction  was 
quenched  with  saturated  tyrosine  solution.  Labeled  protein  was  sepa- 
rated  with  saturated  tyrosine  solution.  Labeled  protein  was  separated 
from free iodine by chromatography on Sephadex G-50 in buffer  B (20 
mM Tris acetate, 20 mM NaCl, 0.1 m.mz EDTA, 0.1%  a-mercaptoethanol, 
pH 7.6) with 0.2% gelatin. 
Pin Assay-Originally, we believed the  site of exit of the p1 cytoplas- 
mic domain from the  membrane to  be the lysine at  position 752, and  the 
sequences of our first set of short  peptides  (SP1-SP4) reflect this.  Dur- 
ing  the  course of these  experiments,  the  consensus  in  the field became 
that  the  site of exit  from the  membrane  is  the  histidine a t position 758, 
and we chose to use this histidine as the first residue in the cyto- 
plasmic  domain for our pin  experiments.  Synthetic  decapeptides  were 
assembled on amino-derivatized  polyethylene  pins  (Cambridge Re- 
search Biochemicals, Wilmington, DE) in solid-phase synthesis from 
Fmoc-amino acid pentachlorophenyl  esters.  The  pins  were  deprotected 
in 20% piperidine in N-methyl-2-pyrrolidinone (NMP) for 30 min, 
washed  in  NMP  for 5 min  and  four  times  in  methanol for 2  min  each, 
allowed to  air  dry for 20 min,  and  immersed  in  NMP  for  2  min  prior to  
coupling. 
For each coupling cycle, fresh 30 p~ stock solutions of the Fmoc- 
amino acid esters  were  prepared  in 1 M 1-hydroxybenzotriazole in NMP 
and  added  to  the  appropriate wells of a polypropylene microtiter  reac- 
tion tray (120 pl/well). The  pins  were  incubated  in  the  reaction  mixture 
for 18 h  in  a covered glass  dish;  washed for 2  min  in  NMP  and  four  times 
for 2  min  each  in  methanol,  and  again  in  NMP for 2 min;  deprotected, 
washed,  air  dried,  and  wet  with  NMP  as  described above. This cycle of 
coupling and deprotecting  was  repeated  until  all  10  amino acid residues 
were  assembled on the pins. 
The  terminal  amino  group of the  assembled  peptides  were  acetylated 
by incubating  the  pins  in 10% acetic  anhydride  and 2% diisopropylene 
in  NMP  (120 pVwel1) for 90  min  in  a covered glass  dish.  The  pins  were 
washed  in  NMP for 5 min  and  four  times  in  methanol  for  2  min  each  and 
air  dried  for  20  min.  The  side-chain  protecting  groups  were removed by 
incubating  the  heads of the  pins  in  19055 (v/v/w) trifluoroacetic acid/ 
ethanedithioVpheno1 for 4 h in a covered glass dish. The pins were 
washed twice in  dichloromethane  (DCM) for 2  min  each, twice in 6:114 
(v/v) diisopropylethylamine/DCM for 2 min each, once in DCM for 5 
min,  and  air  dried for 20 min.  The  pins  were  immersed  in  water for 2 
min  and  in  methanol for 18 h,  and  dried  in  a  vacuum  desiccator for 18 
h or until  required for use. 
For  the  binding  assay,  pins  were blocked with 2% BSA for 2 h  and 
The  abbreviations  used  are: BSA, bovine serum  albumin; TBS, Tris- 
buffered  saline;  PBS,  phosphate-buffered  saline; NMP, N-methyl-2-pyr- 
rolidinone; DCM, dichloromethane; Fmoc, N-(%fluorenyl)methoxycar- 
bonyl. 
incubated  with 1251-a-actinin in  PBS  at room temperature for 2  h  and 
rinsed briefly with 0.1% BSA in  PBS.  Individual  pins  were removed 
from the  rack,  and  the  amount of bound radioactivity  was  determined  in 
a y counter. 
Scrambled  versions of particular  peptide  sequences  were  synthesized 
by using  a  random  number  generator  to  scramble  the  order of the  amino 
acids  (Table  I).  In this  experiment,  the specific activity  and  the concen- 
tration of the  lZ5-a-actinin  were  higher  than  in  the  previous  experiment 
to  increase  the  sensitivity. 
RESULTS 
We have shown previously that  a-actinin binds to both intact 
PI and P3 integrins  and  to a synthetic peptide  corresponding to 
the cytoplasmic domain of PI integrin (Otey et al., 1990). These 
interactions were demonstrated both by affinity  chromatogra- 
phy experiments  in which the peptide was immobilized on a 
column matrix  and by a solid-phase  binding assay  in which the 
peptide or the  integrin was  adsorbed to microtiter wells. In  the 
current study, we have mapped the binding site for a-actinin 
within  the 47 amino  acids of the PI cytoplasmic domain. To this 
end, four shorter slightly  overlapping  peptides (SP1-SP4) were 
synthesized with  an  additional  N-terminal cysteine to  facilitate 
oriented coupling of the peptides to  an affinity matrix (Fig. 1). 
These PI cytoplasmic domain  peptides  were  used in affinity 
chromatography experiments  to  determine which of them was 
able to retain  a-actinin from an  extract of cultured cells. Each 
peptide was linked through  its  N-terminal cysteine residue  to 
thiopropyl-Sepharose 6B, a matrix  that specifically couples to  
free  sulfhydryl  groups. An affinity column was  prepared  using 
each of the four  peptides, and  the four  peptide columns were 
run  in parallel. An extract of cultured chick embryo fibroblasts 
was divided into four aliquots and passed over the peptide 
affinity columns, which were then washed extensively and 
eluted with 300 mM NaCl. To assay for the presence of a-actinin 
in  the column eluates,  samples of protein eluate from each of 
the four  peptide  columns  were resolved by SDS-polyacrylamide 
gel electrophoresis, blotted onto nitrocellulose, and stained 
with a polyclonal antibody to  a-actinin. As shown in Fig. 2, the 
SP2 column bound a  significant amount of a-actinin. A smaller 
but  still detectable amount of a-actinin  was  retained by the SP1 
column, but no a-actinin  was detected by immunoblot analysis 
in  the  eluates from the SP3 and SP4 columns. 
These  results suggested that  the SP2 sequence contributes 
significantly to binding a-actinin,  but  that SP1 also contributes 
to this binding. However, because the level of detectibility in 
TA~LE I 
Sequences of scrambled  peptides 
p,  integrin sequences  Scrambl d  variants 
FAKFEKEKMN KKEANEFKFM
KKANEFMKFE 
KFEKEKMNAK  KKEEMKNKAF 
KKKKNFMEEA 
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~,.~KLLMIIHDRREFAKFEKEKMNAK~TGENPIYKSA-N~K~EGK 
sp1. ~KLLMIIHORREFA 
sn - ~FAKFEKEKMNAKW 
sp3. ~KWDTGENPIYKSA 
S P ~ .  ~AWNPKYEGK 
FIG. 1. Sequence of full-length p1 peptide and short peptides 
SPlSP4. Peptides  contain 13 residues of PI integrin  sequence  plus an  
additional  N-terminal  cysteine for use  in  coupling  the  peptides to an  
affinity  matrix. 
L l 2 3 4  
ing SP1, SP2,  SP3, or SP4. Lane L (column  load)  contains a sample of 
FIG. 2. Immunoblot of eluates from Sepharose columns bear- 
the cell lysate  that  was  applied  to  the  peptide  columns,  which  was  used 
as  a  positive control. Lanes 1 4  contain  samples of material  eluted from 
short  peptide  columns 1-4. Samples  were resolved by SDS-polyacryl- 
amide gel electrophoresis and  transferred  to  nitrocellulose,  then  stained 
with  a  rabbit polyclonal antibody  to  a-actinin and detected  with  horse- 
radish peroxidase-conjugated goat anti-rabbit antibody, reacted with 
H202 and  4-chloro-1-naphthol. 
0 Bl 
0.00 0.25 0.50 0.75 1.00 mg/d 
peptide concentration 
FIG. 3. Binding of 1261-a-actinin to the cytoplasmic domain: 
competition with short peptides. Microtiter  wells  were  coated  with 
the PI full-length  cytoplasmic  domain  peptide and 6 ng of 1251-a-actinin 
(specific activity = 1 x lo7 cpdpg)  were added to each well in the 
presence of increasing  concentrations of PI full-length  peptide or SP1, 
SP2, SP3, or SP4. 
the Western  blot assay  was limited by the  sensitivity of the 
anti-a-actinin antibody, so we investigated  the binding of a-ac- 
tinin  further by using  the four short peptides as competitors in 
a solid-phase binding assay. We have shown previously that 
’251-a-actinin binds  with  moderate affinity to  microtiter wells 
coated with the full-length p1 cytoplasmic domain peptide 
(Otey et al., 1990). In  those  experiments,  it  was shown that  the 
binding of ‘251-a-actinin to  the immobilized peptide  was com- 
petitively  inhibited by addition of free p1 peptide in solution. In 
the  current  experiment, microtiter wells were coated with full- 
length PI peptide and a solution of one of the four short pep- 
tides was added to the wells to determine which of these 
shorter peptides could compete with the immobilized full- 
length p1 peptide for binding to  a-actinin. As shown in Fig. 3, 
SP2 was found to compete  very  strongly for binding of l2‘1-a- 
actinin, while SP1 and SP4 competed less. SP3 had  little  in- 
hibitory effect on the binding of lZ5I-a-actinin to  the full-length 
p1 peptide. Thus,  the  results of the solid-phase  binding assay 
supported  the conclusion that  the sequence of SP2 was impor- 
tant for a-actinin binding, with some  contribution also coming 
from the SP1 sequence. These  results also  suggested that SP4, 
which contained the C terminus of the p1 cytoplasmic domain, 
might also contribute to a-actinin binding. 
In  order  to  investigate  these multiple  sequences  contributing 
to  a-actinin binding  in  more detail, we employed the peptide- 
pin technology used previously for mapping of antibody epit- 
opes (Geysen et al., 1987a, 1987b). Briefly, short peptides  were 
assembled on the  heads of polyethylene pins, as diagrammed in 
Fig. 4. The pins  were held in a special rack  that positions each 
pin in a well of a 96-well microtiter plate.  The peptides  were 
chemically grown by manually  pipetting  the  appropriate  acti- 
vated  amino acid into each well and  immersing  the  heads of the 
pins  in  the  96 reaction wells. As each coupling cycle requires 
only 1 day, this  technique allows the  rapid  simultaneous  as- 
sembly of 96  different short peptides. For our experiments, we 
made every possible sequential decapeptide present in the p1 
cytoplasmic domain, and  three  sets of identical  pins  were con- 
structed.  The pins, with  the  synthetic peptides still covalently 
attached, were blocked with BSA and incubated in ’251-a-acti- 
nin. The  amount of ‘251-a-actinin that bound to each decapep- 
tide pin was  determined by removing the individual  pins from 
the  rack  and counting them  in a y counter (Fig. 5). Fig. 5 shows 
the  results of triplicate  measurements  with  three identical sets 
of pins. The  results obtained with  the  three sets of peptide-pins 
were in close agreement.  Significant  binding of lZ5II-a-actinin 
occurred with decapeptides from two distinct regions of the p1 
cytoplasmic domain. As predicted from the competition data 
shown in Fig. 3, a 10-residue  sequence  contained in SP2 had 
the  highest  aftinity for a-actinin (FAKFEKEKMN), and a sec- 
ond cluster of decapeptide  sequences near  the C terminus of the 
p1 cytoplasmic domain  also bound a significant amount of a-ac- 
tinin. 
A desirable control for any  synthetic peptide  experiment is  to 
test  the binding  activity of a “scrambled”  peptide, i.e. a peptide 
with  the  same  amino acid composition as  an active  peptide, but 
arranged  in a random order. Using the pin technique, we con- 
structed two different scrambled peptides for each of the p1 
sequences that  had bound a large  amount of a-actinin  in  the 
previous assay. As shown in Fig. 6, scrambled  versions of the 
most active p1 sequence (FAKFEKEKMN) bound only back- 
ground levels of a-actinin. However, scrambling of the active 
sequences near  the C terminus of the p1 cytoplasmic domain 
did not reduce the binding of a-actinin,  and  in some  cases the 
binding to the scrambled peptides was greater than to the 
original p1 peptides from the C terminus. This suggests  that 
a-actinin binding to  these C-terminal  peptides is more depend- 
ent  on  the composition of the peptides rather  than  their se- 
- 
acetyl peplie 8.alanlne 1.6a~rnlmnerane 
FIG. 4. Schematic of the peptide-pin constructs. The  pins  were 
purchased  pre-grafted  with an  acrylic  acid that  was coupled to  a  regu- 
lated  amount of mono-t-butyloxycarbonyl-1,6-diaminohexane and  then 
to the active ester of Fmoc-P-alanine. The peptides were assembled 
using Fmoc chemistry,  and  the  N  termini of the peptides  were acety- 
lated  with  acetic  acid  to  prevent  end effects caused by charged  N  ter- 
mini. 
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FIG. 5. Binding of lzSI-a-actinin to 
peptide-pin  constructs. Peptides corre- 
sponding to each consecutive 10-residue 
sequence in the cytoplasmic domain of 
integrin were synthesized on the heads of 
pins and incubated in a solution of lZ5I-a- 
actinin. The amount of 1251-a-actinin 
bound to each peptide-pin construct is 
shown as counts bound (cpm), and the se- 
quence of each peptide is shown on the 
lower axis. The data shown were averaged 
from experiments with three identical 
sets of peptide-pins, and the specific ac- 
tivity of the 1251-a-actinin was the  same as 











quence. Consistent  with  this,  these peptides are relatively un- 
charged and hydrophobic. 
DISCUSSION 
Previous work has shown that  a-actinin binds to  the cyto- 
plasmic  domain of the p subunit of intact  integrins from both 
the p1 and p3 subfamilies  (Otey et al., 1990). In this study, we 
have  attempted to define the binding site for a-actinin  within 
the p1 integrin cytoplasmic domain. We have  used  short syn- 
thetic p1 integrin peptides to  assess  a-actinin binding in  three 
different formats;  the peptides were immobilized on an affinity 
matrix or on polyethylene pins, or they  were free in solution in 
microtiter wells. The mimotope (peptide-pin) assay was origi- 
nally designed to  map epitopes recognized by specific antibod- 
ies  (Geysen et al., 1987a,  1987b) and for this  usage it is common 
to  construct 7- or 8-residue peptides. Our peptide-pin  experi- 
ments  represent a novel application of this technology to  map 
the  interactive  sites on two structural proteins. We used longer 
10-residue peptides to  increase  the size of the peptide  binding 
sites being tested.  In  determining  the pi sequences with  the 
scrambled  peptide-pin  constructs. 
FIG. 6. Binding of lZ6I-a-actinin to 
Peptides that bound a-actinin in  the pre- 
vious peptide-pin assay (solid bars) and 
two scrambled variants of each (open and 
heads of pins and incubated in lZ5I-a-ac- 
hatched bars) were synthesized on the 
tinin. The amount of lZ5I-a-actinin bound 
to  each peptide-pin construct is shown as 
counts bound (cpm). The specific activity 
of the lZ5I-a-actinin was 5 x 10' cpdpg. 
greatest  binding of a-actinin, all three types of assays  were  in 
agreement  that  the  primary p1 segment involved in  a-actinin 
binding is contained within  the sequence FAKFEKEKMN. Re- 
sults from the microtiter assay  and  the pin assay also confirm 
the presence of a second pi segment involved in  a-actinin bind- 
ing  near  the C terminus of the p1 cytoplasmic domain. In  these 
experiments, we tested  the binding activity of the  linear 
sequence, but  it is possible that folding of the cytoplasmic do- 
main  in  the  native  integrin may bring  these two segments close 
together, such  that  they both contribute to a single three di- 
mensional a-actinin binding site.  This folding is plausible be- 
cause midway between the two binding segments  is a GXXP 
sequence,  which could produce a turn or loop. 
The two clusters of peptides involved in  a-actinin binding 
have very different characteristics. The N-terminal peptides 
(e.g. FAKFEKEKMN) are highly  charged and  have  alternating 
lysines and  glutamic acid residues. On  the  other  hand, 
the  C-terminal peptides are relatively hydrophobic, containing 
a single  lysine. In  this  cluster of C-terminal peptides, there are 
no negatively charged amino acids and binding is lost in 
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crucial for  focal adhesion localization underlined  (adapted from Fkszka 
FIG. 7. IIbp line, sequence of the p1 cytoplasmic  domain, with residues 
et al. (1992)). Lower lines, sequences of the three peptides with the 
highest affinity for a-actinin in the peptide-pin assay. 
adjacent peptides when these include an N-terminal or C-ter- 
minal glutamic acid.  With this group of peptides, it is interest- 
ing that seven  successive, overlapping peptides all bind with 
one  exception. This peptide has  the sequence KSAVTTVVNP. It 
is striking that  the next peptide has  an identical composition, 
but the lysine is now C-terminal rather  than N-terminal, and 
this peptide binds well. We suspect that  the lack of binding by 
the one peptide is due to the C-terminal proline attached to the 
p-alanine of the  link to the plastic pin. A cis-proline turn would 
facilitate the interaction of the hydrophobic interior of the de- 
capeptide with the methylene groups of the hydrophobic spacer. 
As a consequence the peptide would be folded back on the 
spacer and unavailable to  interact with a-actinin. Introducing 
the positively charged lysine C-terminal to the proline may 
prevent the peptide from interacting with the hydrophobic 
spacer and so restore binding. This points to one of the poten- 
tial drawbacks of using synthetic peptides for studying protein- 
protein interactions, which is that  the mode of presentation of 
the peptide can affect its conformation. We have chosen to use 
three different formats for our assays in an effort to minimize 
spurious results generated by non-native peptide conforma- 
tions. 
At first, we were surprised that our attempts to scramble the 
sequences of the a-actinin-binding peptides in the C-terminal 
region generally led to no diminution of binding and sometimes 
resulted in enhanced binding. These results suggest that  the 
order of amino acids is less critical than  the overall composi- 
tion. As noted above, the peptides in this region are predomi- 
nantly hydrophobic, but also contain 1 serine  and 2 threonines. 
In general, the peptides from this region and  their scrambled 
variants  that bind appear to have two hydrophobic patches, 
which we conclude must contribute to the binding. It is not 
surprising that scrambling these peptides will frequently main- 
tain hydrophobic patches and thus maintain binding. 
At the N-terminal end of the cytoplasmic sequence, we have 
consistently found that  the peptide FAKFEKEKMN binds a-ac- 
tinin most  effectively in the pin analysis. Two scrambled ver- 
sions of this sequence showed  no significant binding. However, 
the immediately preceding and subsequent peptides did not 
bind, although the next two peptides did  bind. Comparing t,he 
sequences, we note that  the  three sequences that  are active in 
this region have a phenylalanine in position 1 or 2, a lysine in 
positions 3 or 4, and a glutamic acid in position 4 or 5, suggest- 
ing that the sequence FXKE may be critical in forming an 
active a-actinin binding segment. Scrambling the other two 
binding peptides in this region resulted, surprisingly, in pep- 
tides which  bound a-actinin even though they did not contain 
the FXKE motif. Currently, we do not have a satisfactory ex- 
planation for these findings. They  will  be pursued further. 
In the study that first demonstrated an interaction between 
a-actinin  and p1 integrin,  a-actinin bound with equal affinity to 
purified integrins from the p1 and p3 subfamilies (Otey et al., 
1990). Our  current data indicate that a primary binding se- 
quence for a-actinin is the sequence FAKFEKEKMN, which 
corresponds to the sequence FAKFEEERAR in p3. Thus, the p1 
and p3 integrins  share  a high degree of  homology in this a-ac- 
tinin binding segment, with 6 out of 10 residues being identical. 
The published sequences of other p integrins reveal that  the 
FXKE motif is also present in pz integrin (YRRFEKEKLK), 
which suggests that  this integrin subfamily may also share  a 
conserved a-actinin binding activity. 
It  is interesting to compare our  results to the recent work of 
Reszka and co-workers (1992). They transfected chicken p1 
integrins  into mouse  cells and assayed for  localization of the 
chicken integrins to focal adhesions by immunofluorescence 
staining with a chicken-specific integrin antibody. Using site- 
directed mutagenesis, they identified 10 noncontiguous resi- 
dues in the p1 cytoplasmic  domain that  are important in di- 
recting the transfected integrins to the focal adhesions. If these 
residues are varied, the integrin is expressed but  has  a diffuse 
localization pattern. Comparison of our a-actinin binding data 
and their site-directed mutagenesis data shows that 9 out of 
these 10 residues are contained within the two sites that were 
found to have a high affinity for a-actinin in our peptide-pin 
experiments (Fig. 7). Although it is very likely that other focal 
adhesion proteins besides a-actinin  are involved in targeting 
integrins to the focal adhesions, our results are consistent with 
a-actinin playing a significant role in this localization. 
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